FGF23 and cardiac hypertrophy: After correction for age, sex and interim valvular interventions, FGF23 was the only biomarker next to NT-proBNP significantly associated with pressure overload, consistent with its role in ventricular hypertrophy and myocardial damage [[35], [36], [37], [38]].